NMBU - Norwegian University of Life Sciences
TrustedOverview
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 1, 2026 | ChemoTech’s TSE Reports 97% Complete Remission and Stronger Than Expected Clinical Results in Equine | ChemoTech’s TSE Reports 97% Complete Remission and Stronger Than Expected Clinical Results in Equine Wed, Jul 01, 2026 12:46 CET Report this content Scandinavian ChemoTech AB provides an update regarding the clinical abstract on Tumour Spec... |
| Jul 1, 2026 | Clinical Publication on TSE Therapy for the Treatment of Equine Sarcoids to Be Presented During ECVS | Clinical Publication on TSE Therapy for the Treatment of Equine Sarcoids to Be Presented During ECVS Wed, Jul 01, 2026 08:30 CET Report this content As previously announced on 18th of February 2026, Scandinavian ChemoTech’s Animal Care busi... |
| Feb 19, 2026 | (RETRANS) Clinical Study on TSE in Equine Sarcoid Mgmt. to be presented at the upcoming ECVS Meeting. | (RETRANS) Clinical Study on TSE in Equine Sarcoid Mgmt. to be presented at the upcoming ECVS Meeting. Thu, Feb 19, 2026 08:45 CET Report this content Retransmission of the press release that was published, with the associated MAR label, on ... |
| Feb 18, 2026 | Clinical Study on TSE in Equine Sarcoid Management to be presented at the upcoming ECVS Meeting | Clinical Study on TSE in Equine Sarcoid Management to be presented at the upcoming ECVS Meeting Wed, Feb 18, 2026 20:50 CET Report this content Scandinavian ChemoTech today announced that a clinical study conducted by Prof. Cathrine T. Fjor... |
| Mar 31, 2025 | Navigating the Future: Compliance and Innovation in the iGaming and Biotech Sectors | In the fast-paced world of business, two sectors are making waves: iGaming and biotechnology. Both are navigating complex landscapes filled with regulations, innovation, and opportunities. As they evolve, the importance of compliance and cu... |
| Mar 28, 2025 | Diagonal Bio publishes Year-End Report for 2024 | Diagonal Bio publishes Year-End Report for 2024 Fri, Mar 28, 2025 08:00 CET Report this content Read original Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") hereby publishes its year-end report for the financia... |
| Nov 5, 2024 | ChemoTech’s Animal Care Enters Strategic Collaboration with Norwegian Veterinary University’s Hospital for Equine Medicine | ChemoTech’s Animal Care Enters Strategic Collaboration with Norwegian Veterinary University’s Hospital for Equine Medicine Tue, Nov 05, 2024 09:20 CET Report this content Scandinavian ChemoTech AB’s subsidiary dedicated to Animal Care has e... |
| Oct 31, 2024 | Diagonal Bio AB Third Quarter Report (Q3 2024) | Diagonal Bio AB Third Quarter Report (Q3 2024) Thu, Oct 31, 2024 08:00 CET Report this content Read original “One of the most exciting developments is our effort into a new application of our technology LAMPlify®—this time in the domain of ... |
| Oct 25, 2024 | Diagonal Bio announces pilot test of LAMPlify® at Norwegian University of Life Sciences | Diagonal Bio announces pilot test of LAMPlify® at Norwegian University of Life Sciences Fri, Oct 25, 2024 14:15 CET Report this content Read original Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces the... |
Reviews 0
FAQ about NMBU - Norwegian University of Life Sciences
When was NMBU - Norwegian University of Life Sciences founded?
NMBU - Norwegian University of Life Sciences was founded in 1859.
What has the press written about NMBU - Norwegian University of Life Sciences?
Parsers VC has collected 14 articles mentioning NMBU - Norwegian University of Life Sciences, among them “ChemoTech’s TSE Reports 97% Complete Remission and Stronger Than Expected Clinical Results in Equine” (Jul 1, 2026) and “Clinical Publication on TSE Therapy for the Treatment of Equine Sarcoids to Be Presented During ECVS” (Jul 1, 2026).
Is NMBU - Norwegian University of Life Sciences still active?
Yes, NMBU - Norwegian University of Life Sciences is active; its latest activity on Parsers VC dates from Aug 11, 2026.